Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated CBT and Varenicline for Smoking Cessation in Heavy Drinkers
NCT02151591Phase 1Completed
- Sponsor
- Yale University
- Start
- Mar 2017
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Yale University. Primary endpoint: Number of Participants With Smoking Abstinence at 6 months. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT02151591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151591.